PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanolic root extract induced apoptosis in A549 lung cancer cells [PMID: 20953431, 20869020] and showed anticancer potential against benzo[a]pyrene-induced lung cancer in mice [PMID: 21419086].
Senegin-II and senegasaponins significantly reduced blood glucose levels in normal and non-insulin dependent diabetic (KK-Ay) mice [PMID: 8923811, 9214731, 8535417, 8582013, 8706138].
Extract fractions significantly inhibited LPS-induced inflammatory cytokines IL-1beta, IL-6, and TNFalpha in murine macrophage RAW 164.7 cells [PMID: 19577624].
Saponins from the root acted as adjuvants, increasing specific antibody responses and IL-2 levels in mice [PMID: 18066120, 10660256].
Senegasaponins and senegins exhibited inhibitory effects on ethanol absorption in rats [PMID: 7728939, 8582013, 8706138].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 20953431 (2011) — Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form. · Evidence-based complementary and alternative medicine : eCAM
- 2.PMID: 34730980 (2021) — Preparation of Tenuifolin from Polygala senega L. Root Using a Hydrolytic Continuous Flow System under High-Temperature, High-Pressure Conditions. · The Journal of organic chemistry
- 3.PMID: 18066120 (2007) — Adjuvant activities of saponins from the root of Polygala senega L. · Canadian journal of physiology and pharmacology
- 4.PMID: 21419086 (2011) — Anticancer potentials of root extract of Polygala senega against benzo[a]pyrene-induced lung cancer in mice. · Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
- 5.PMID: 20869020